Key result
This review summarizes the molecular mechanisms of RNA virus infection, host-virus interactions, and recent progress in RNA-based therapeutics like mRNA vaccines and ASO drugs.
This review provides a comprehensive overview of RNA virus interaction mechanisms and highlights the potential of RNA-based therapeutics for prevention and control.
RNA virus effects on host RNA processing may reveal antiviral targets; leaves open validation in clinical cohorts.
RNA viruses are a class of viruses with ribonucleic acid (RNA) as genomic genetic material, including some important human and animal pathogens, such as influenza, SARS-CoV-2, Ebola, and other highly pathogenic viruses. RNA virus infection affects the regulation of RNA processing in host cells, such as alternative splicing, polyadenylation, RNA modification, and RNA degradation. These changes affect the replication and translation of the virus’s own RNA, as well as its immune escape and pathogenicity. In the invaded cells, viral RNAs use the host molecular machine to produce the proteins encoded by the virus itself. These viral RNA and protein macromolecules form a complex interaction network with host proteins and RNAs in regulating the replication of the virus and the host response. In this review, we systematically examine the types and characteristics of RNA viruses, including the representative viruses and the harm they cause. We also summarize recent progress on the molecular events and mechanisms of RNA viruses after infecting cells, including the regulated RNA processing of viral and host RNAs, viral RNA-protein, and other macromolecular interactions. Finally, we introduce the new progress and challenges of RNA-based therapeutic methods, such as mRNA vaccines and ASO drugs, in preventing and treating RNA viruses.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2025) conducted a review in RNA virus infection. This review summarizes the molecular mechanisms of RNA virus infection, host-virus interactions, and recent progress in RNA-based therapeutics like mRNA vaccines and ASO drugs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: